Posted by Michael Wonder on 29 Jan 2020
Cancer patients facing delays in getting ‘innovative’ drugs
29 January 2020 - A new analysis report has found that most innovative cancer drugs face delays in reaching patients.
Researchers at The Institute of Cancer Research have now discovered that cancer patients are waiting longer for innovative new cancer drugs than for more conventional treatments, which suggests that the most “exciting” new therapies have not been successfully fast tracked.
As such, the team uncovered that the higher the level of innovation of a cancer drug, the longer it was taking to pass through clinical trials, licensing and appraisal for availability on the NHS.
